Catalyst Pharmaceuticals
Trade Catalyst Pharmaceuticals 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About CPRX
Catalyst Pharmaceuticals, Inc. is a commercial-stage, patient-centric biopharmaceutical company, which focuses on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult to treat diseases. The company was founded by Hubert E.
CPRX Key Statistics
Stock Snapshot
As of today, Catalyst Pharmaceuticals(CPRX) shares are valued at $31.17. The company's market cap stands at 3.83B, with a P/E ratio of 17.98.
On 2026-05-22, Catalyst Pharmaceuticals(CPRX) stock moved within a range of $31.17 to $31.30. With shares now at $31.17, the stock is trading 0.0% above its intraday low and -0.4% below the session's peak.
Trading activity shows a volume of 1.99M, compared to an average daily volume of 2.99M.
Over the past 52 weeks, Catalyst Pharmaceuticals(CPRX) stock has traded between a high of $32.56 and a low of $19.05.
Over the past 52 weeks, Catalyst Pharmaceuticals(CPRX) stock has traded between a high of $32.56 and a low of $19.05.
CPRX News
Catalyst Pharmaceuticals, ticker NasdaqCM:CPRX, has agreed to be acquired by Angelini Pharma in a definitive all cash transaction. The company has settled all...
Analyst ratings
67%
of 6 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.